212 related articles for article (PubMed ID: 30514252)
1. YKL-40 levels are associated with disease severity and prognosis of viral pneumonia, but not available in bacterial pneumonia in children.
Yang X; Sheng G
BMC Pediatr; 2018 Dec; 18(1):381. PubMed ID: 30514252
[TBL] [Abstract][Full Text] [Related]
2. YKL-40, CCL18 and SP-D predict mortality in patients hospitalized with community-acquired pneumonia.
Spoorenberg SM; Vestjens SM; Rijkers GT; Meek B; van Moorsel CH; Grutters JC; Bos WJ;
Respirology; 2017 Apr; 22(3):542-550. PubMed ID: 27782361
[TBL] [Abstract][Full Text] [Related]
3. Measurement of lipocalin-2 and syndecan-4 levels to differentiate bacterial from viral infection in children with community-acquired pneumonia.
Esposito S; Bianchini S; Gambino M; Madini B; Di Pietro G; Umbrello G; Presicce ML; Ruggiero L; Terranova L; Principi N
BMC Pulm Med; 2016 Jul; 16(1):103. PubMed ID: 27439403
[TBL] [Abstract][Full Text] [Related]
4. Serum YKL-40 is a reliable biomarker for pulmonary alveolar proteinosis.
Bonella F; Long X; He X; Ohshimo S; Griese M; Guzman J; Costabel U
Respirology; 2017 Oct; 22(7):1371-1378. PubMed ID: 28569052
[TBL] [Abstract][Full Text] [Related]
5. Serum YKL-40 as predictor of outcome in hypersensitivity pneumonitis.
Long X; He X; Ohshimo S; Griese M; Sarria R; Guzman J; Costabel U; Bonella F
Eur Respir J; 2017 Feb; 49(2):. PubMed ID: 27836954
[TBL] [Abstract][Full Text] [Related]
6. Course of SP-D, YKL-40, CCL18 and CA 15-3 in adult patients hospitalised with community-acquired pneumonia and their association with disease severity and aetiology: A post-hoc analysis.
Spoorenberg SMC; Vestjens SMT; Voorn GP; van Moorsel CHM; Meek B; Zanen P; Rijkers GT; Bos WJW; Grutters JC;
PLoS One; 2018; 13(1):e0190575. PubMed ID: 29324810
[TBL] [Abstract][Full Text] [Related]
7. Serum YKL-40 as a potential biomarker of inflammation in psoriasis.
Baran A; Myśliwiec H; Szterling-Jaworowska M; Kiluk P; Świderska M; Flisiak I
J Dermatolog Treat; 2018 Feb; 29(1):19-23. PubMed ID: 28498006
[TBL] [Abstract][Full Text] [Related]
8. Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children.
Toikka P; Irjala K; Juvén T; Virkki R; Mertsola J; Leinonen M; Ruuskanen O
Pediatr Infect Dis J; 2000 Jul; 19(7):598-602. PubMed ID: 10917215
[TBL] [Abstract][Full Text] [Related]
9. Serum YKL-40 levels may help distinguish exacerbation of post-infectious bronchiolitis obliterans from acute bronchiolitis in young children.
Jang YY; Park HJ; Chung HL
Eur J Pediatr; 2017 Jul; 176(7):971-978. PubMed ID: 28567534
[TBL] [Abstract][Full Text] [Related]
10. The chitinase-like protein YKL-40: a possible biomarker of inflammation and airway remodeling in severe pediatric asthma.
Konradsen JR; James A; Nordlund B; Reinius LE; Söderhäll C; Melén E; Wheelock AM; Lödrup Carlsen KC; Lidegran M; Verhoek M; Boot RG; Dahlén B; Dahlén SE; Hedlin G
J Allergy Clin Immunol; 2013 Aug; 132(2):328-35.e5. PubMed ID: 23628340
[TBL] [Abstract][Full Text] [Related]
11. Clinical Utility of YKL-40 in Polymyositis/dermatomyositis-associated Interstitial Lung Disease.
Hozumi H; Fujisawa T; Enomoto N; Nakashima R; Enomoto Y; Suzuki Y; Kono M; Karayama M; Furuhashi K; Murakami A; Inui N; Nakamura Y; Mimori T; Suda T
J Rheumatol; 2017 Sep; 44(9):1394-1401. PubMed ID: 28711881
[TBL] [Abstract][Full Text] [Related]
12. Cytokine expression in severe pneumonia: a bronchoalveolar lavage study.
Montón C; Torres A; El-Ebiary M; Filella X; Xaubet A; de la Bellacasa JP
Crit Care Med; 1999 Sep; 27(9):1745-53. PubMed ID: 10507593
[TBL] [Abstract][Full Text] [Related]
13. Pretransplant serum human chitinase-like glycoprotein YKL-40 concentrations independently predict bronchiolitis obliterans development in lung transplant recipients.
Jaksch P; Taghavi S; Klepetko W; Salama M
J Thorac Cardiovasc Surg; 2014 Jul; 148(1):273-81. PubMed ID: 24685381
[TBL] [Abstract][Full Text] [Related]
14. Systemic cytokine levels in community-acquired pneumonia and their association with disease severity.
Antunes G; Evans SA; Lordan JL; Frew AJ
Eur Respir J; 2002 Oct; 20(4):990-5. PubMed ID: 12412694
[TBL] [Abstract][Full Text] [Related]
15. YKL-40 (Chitinase-3-Like Protein 1) Serum Levels in Aortic Stenosis.
Arain F; Abraityte A; Bogdanova M; Solberg OG; Michelsen AE; Lekva T; Aakhus S; Holm S; Halvorsen B; Finsen AV; Vinge LE; Nymo S; Espeland T; Ranheim T; Aukrust P; Vaage IJ; Auensen A; Gullestad L; Ueland T
Circ Heart Fail; 2020 Oct; 13(10):e006643. PubMed ID: 32962417
[TBL] [Abstract][Full Text] [Related]
16. Can YKL-40 be used as a biomarker for interstitial lung disease?: A systematic review and meta-analysis.
Tong X; Ma Y; Liu T; Li Z; Liu S; Wu G; Fan H
Medicine (Baltimore); 2021 Apr; 100(17):e25631. PubMed ID: 33907118
[TBL] [Abstract][Full Text] [Related]
17. [Changes in serum YKL-40 level and humoral immune function and their significance in children with recurrent pneumonia].
Ma WY; Peng S; Zhang T
Zhongguo Dang Dai Er Ke Za Zhi; 2017 Apr; 19(4):425-429. PubMed ID: 28407830
[TBL] [Abstract][Full Text] [Related]
18. Disease indicators for sepsis and analysis of sepsis treatment in children using the continuous blood purification technique.
Liu JP; Wang XW; Qie LP
Genet Mol Res; 2015 May; 14(2):5685-93. PubMed ID: 26125767
[TBL] [Abstract][Full Text] [Related]
19. Airway, but not serum or urinary, levels of YKL-40 reflect inflammation in early cystic fibrosis lung disease.
Fantino E; Gangell CL; Hartl D; Sly PD;
BMC Pulm Med; 2014 Feb; 14():28. PubMed ID: 24576297
[TBL] [Abstract][Full Text] [Related]
20. [Association of YKL-40 in bronchoalveolar lavage fluid with airway damage in children with Mycoplasma pneumoniae pneumonia].
Huang LL; Li RH; Li J; Chen HJ; Peng SM
Zhongguo Dang Dai Er Ke Za Zhi; 2019 Dec; 21(12):1188-1192. PubMed ID: 31874657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
